Abstract | OBJECTIVE: METHOD: Patients who met DSM-IV criteria for bulimia nervosa, purging type, were assigned to single-blind treatment with 60 mg/day of fluoxetine. After 8 weeks of treatment, patients were considered responders if they experienced a decrease > or =50% from baseline in the frequency of vomiting episodes during 1 of the 2 preceding weeks. Responders were randomly assigned to receive 60 mg/day of fluoxetine or placebo and were monitored for relapse for up to 52 weeks. Patients met relapse criteria if they experienced a return to the baseline vomiting frequency that persisted for 2 consecutive weeks. RESULTS: Of the 232 patients who entered the acute phase, 150 patients (65%) met response criteria and were randomly assigned to receive fluoxetine (N=76) or placebo (N=74). Fluoxetine-treated patients exhibited a longer time to relapse than placebo-treated patients. Quantitative analysis of other efficacy measures, including frequency of vomiting episodes, frequency of binge eating episodes, Clinical Global Impression severity and improvement scores, the patient's global impression score, and Yale-Brown-Cornell Eating Disorder Scale score, indicated that the efficacy of fluoxetine treatment was statistically superior, compared to placebo. There were no clinically relevant differences in safety between groups. Attrition in this study was high, especially in the first 3 months after random assignment to treatment groups. CONCLUSIONS: Continued treatment with fluoxetine in patients with bulimia nervosa who responded to acute treatment with fluoxetine improved outcome and decreased the likelihood of relapse.
|
Authors | Steven J Romano, Katherine A Halmi, Neena P Sarkar, Stephanie C Koke, Julia S Lee |
Journal | The American journal of psychiatry
(Am J Psychiatry)
Vol. 159
Issue 1
Pg. 96-102
(Jan 2002)
ISSN: 0002-953X [Print] United States |
PMID | 11772696
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Bulimia
(diagnosis, drug therapy, psychology)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Fluoxetine
(administration & dosage, adverse effects)
- Follow-Up Studies
- Humans
- Long-Term Care
- Male
- Psychiatric Status Rating Scales
- Recurrence
- Single-Blind Method
- Treatment Outcome
|